DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership

DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95. The analyst maintained his Buy rating on the stock. DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership Plovanic noted that fourth-quarter results and 2026 outlook met expectations, as the company’s strategy remains unchanged. Management continues to fo ...